Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Entero Therapeutics ( (ENTO) ) is now available.
Entero Therapeutics has appointed Jason D. Sawyer as the Interim Chief Executive Officer, effective September 4, 2025. The company has entered into a consulting agreement with Mr. Sawyer, providing him with a monthly compensation of $12,500 and indemnification under Delaware General Corporation Law, reflecting a strategic move in its leadership structure.
More about Entero Therapeutics
Average Trading Volume: 1,887,863
Technical Sentiment Signal: Sell
Current Market Cap: $3.65M
See more data about ENTO stock on TipRanks’ Stock Analysis page.